Bolt Biotherapeutics Inc. share price logo

Bolt Biotherapeutics Inc.

NASDAQ: BOLT

$4.07

+0.02

(+0.37%)

as on

Bolt Biotherapeutics Inc. Stock Performance

as on July 7, 2026 at 6:59 am IST

  • Day's Low

    Day's High

    $3.80
    $4.25
    downward going graph

    6.63%

    Downside

    4.42%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $3.75
    $7.20
    downward going graph

    7.86%

    Downside

    76.90%

    Upside

    downward going graph

Bolt Biotherapeutics Inc. share price movements today

Previous Close
$4.05
Open
$3.94
Volume
661.5K
Day's Low - High
$3.80 - $4.25
52 Week Low - High
$3.75 - $7.20

Bolt Biotherapeutics Inc. Historical Returns

1 Month Return
-11.18 %
3 Month Return
-17.85 %
1 Year Return
-31.59 %
3 Year Return
-85.64 %
5 Year Return
-98.58 %

Bolt Biotherapeutics Inc. Stock Fundamentals & Key Indicators

Check Bolt Biotherapeutics Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$7.8M

EPS (TTM)

-238.2833

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

EBITDA

-29.0M

Revenue (TTM)

6.5M

Profit Margin

0.00%

Return On Equity TTM

-88.79%

Bolt Biotherapeutics Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Bolt Biotherapeutics Inc. with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
Bolt Biotherapeutics Inc. image
Bolt Biotherapeutics Inc.
BUY$7.8M-98.58%NA0.00%NA
Revolution Medicines Inc. image
Revolution Medicines Inc.
BUY$40.2B501.91%NA0.00%NA
Alnylam Pharmaceuticals Inc. image
Alnylam Pharmaceuticals Inc.
BUY$41.8B79.37%78.7912.55%NA
Vertex Pharmaceuticals Inc. image
Vertex Pharmaceuticals Inc.
BUY$134.0B163.95%31.3635.51%NA
Regeneron Pharmaceuticals Inc. image
Regeneron Pharmaceuticals Inc.
BUY$68.6B12.37%15.9729.65%0.5700000000000001%

Stock Returns calculator for Bolt Biotherapeutics Inc. Stock including INR - Dollar returns

The Bolt Biotherapeutics Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

Bolt Biotherapeutics Inc. investment value today

Current value as on today

₹76,474

Returns

-₹23,526

(-23.53%)

Returns from Bolt Biotherapeutics Inc. Stock

-₹31,250 (-31.25%)

Dollar Impact

₹7,724 (+7.72%)

Analyst Recommendation on Bolt Biotherapeutics Inc. Stock

Based on 12 analysts

BUY

83.33%

Buy

16.67%

Hold

0.00%

Sell

Based on 12 analysts, 83.33% of analysts recommend a 'BUY' rating for Bolt Biotherapeutics Inc.. Average target price of $41

Bolt Biotherapeutics Inc. Share Price Target

Get share price movements and forecasts by analysts on Bolt Biotherapeutics Inc..

What analysts predicted

90.07%UPSIDE

Target Price

$41

Current Price

$4.07

Analyzed by

12 Analysts

Target

$41.00

Bolt Biotherapeutics Inc. target price $41, a slight upside of 90.07% compared to current price of $4.07. According to 12 analysts rating.

Indian Investors' Interest in Bolt Biotherapeutics Inc. Stock

Search interest for Bolt Biotherapeutics Inc. Stock has decreased by -36% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-36% versus previous 30 day period

Bolt Biotherapeutics Inc. Quarterly Profit & Loss

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Total Revenue
2
5
1
1
24
1
1
2
2
0
Gross Profit
-14
4
-14
-12
0
1
1
2
2
0
Operating Income
-19
-17
-22
-16
-15
-12
-9
-7
-5
-7
EBITDA
-17
-10
-18
-14
-15
-10
-8
-6
-6
-7
Interest Expense
1
-
-
-
-
-
-
-
-
-
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-17
-10
-21
-15
-15
-11
-8
-7
-6
-7
Income Tax Expense
1
0
-
-
-
-
-
-
-
-
Net Income
-17
-10
-21
-15
-15
-11
-8
-7
-6
-7
Net Profit Margin
-857.01%
-204.99%
-1662.35%
-1330.06%
-66.15%
-903.44%
-474.56%
-329.37%
-265.24%
-27861.54%

Bolt Biotherapeutics Inc. Annual Profit & Loss

All numbers in Millions USD

Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
0
0
1
5
7
7
7
Gross Profit
0
0
-40
-74
-67
-53
7
6
Operating Income
-11
-30
-49
-92
-90
-76
-73
-34
EBITDA
-11
-30
-48
-97
-86
-67
-66
-31
Interest Expense
-
-
-
5
2
-
-
-
Depreciation
0
0
0
1
1
1
1
1
Income Before Tax
-11
-30
-60
-98
-88
-69
-63
-33
Income Tax Expense
0
0
11
5
-2
1
-
-
Net Income
-11
-30
-60
-98
-88
-69
-63
-33
Net Profit Margin
0.00%
-14180.00%
-26289.18%
-7824.68%
-1537.76%
-878.58%
-820.78%
-433.74%

Bolt Biotherapeutics Inc. Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Net Income
-10
-21
-15
-15
-11
-8
-7
-6
-7
Operating Cash Flow
-16
-16
-13
-14
-13
-9
-9
-7
-8
Investing Cash Flow
10
18
17
12
14
10
17
1
7
Financing Cash Flow
-
0
-
0
-
0
-
0
0
Change in Cash
-6
1
3
-2
1
1
8
-6
0

Bolt Biotherapeutics Inc. Annual Cash Flow

All numbers in Millions USD

Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-30
-60
-98
-88
-69
-63
-33
Operating Cash Flow
-26
-47
-57
-76
-69
-61
-39
Investing Cash Flow
0
-20
-232
57
71
57
44
Financing Cash Flow
48
39
311
0
0
0
0
Change in Cash
21
-28
21
-18
1
-3
4

Global Institutional Holdings in Bolt Biotherapeutics Inc.

Funds
Holdings
Pfizer Inc
1.63%
Shay Capital LLC
0.78%
SBI Securities Co Ltd
0%
UBS Group AG
0.04%
Susquehanna International Group, LLP
0.61%
See all

Insights on Bolt Biotherapeutics Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Revolution Medicines, Inc. Common Stock has given 617.1% return, outperforming this stock by 702.8%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Revolution Medicines, Inc. Common Stock has given 416.1% return, outperforming this stock by 447.1%

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 2 quarters, 2.5M → 26.0K (in $), with an average decrease of 99.0% per quarter

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 2 quarters, -6.63M → -7.24M (in $), with an average decrease of 9.2% per quarter

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 3 years, BOLT stock has moved down by -85.7%

About Bolt Biotherapeutics Inc.

Bolt Biotherapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel immunotherapies for the treatment of cancer. The company's pipeline products include BDC-4182, a next-generation Boltbody ISAC that targets the tumor-associated antigen claudin 18.2 for the treatment of gastric/gastroesophageal junction cancer, pancreatic cancer, and other tumor types; BDC-3042, a dectin-2 agonist antibody program for the treatment of non-small cell lung cancer, melanoma, and other solid tumors; CEA ISAC, a Boltbody ISAC targeting carcinoembryonic antigen cell adhesion molecule 5 for the treatment of solid tumors, including colorectal, non-small cell lung, pancreatic, and breast; and PD-L1 ISAC, a novel human anti-PD-L1 antibody conjugated to a next-generation TLR7/8 agonist payload via a non-cleavable linker to target both tumor and immune cells for the treatment of tumor regression and immunological memory. The company has collaboration agreements with Toray Industries, Genmab A/S, and Innovent Biologics, Inc.; and a license agreement with Stanford University. The company was formerly known as Bolt Therapeutics, Inc. and changed its name to Bolt Biotherapeutics, Inc. in July 2015. Bolt Biotherapeutics, Inc. was incorporated in 2015 and is headquartered in Redwood City, California.
OrganisationBolt Biotherapeutics Inc.
Headquarters900 Chesapeake Drive, Redwood City, CA, United States, 94063
IndustryBiotechnology
CEOMr. William P. Quinn
E-voting on sharesClick here to vote

Key Management of Bolt Biotherapeutics Inc.

Name

Title

Mr. William P. Quinn

CEO, CFO, President, Secretary & Director

Mr. Grant Yonehiro C.F.A., M.B.A.

COO & Chief Business Officer

Ms. Sarah Nemec

Senior VP of Finance & Principal Accounting Officer

Dr. Michael N. Alonso Ph.D.

Senior Vice President of Research

Mr. Justin Kenkel

Senior Principal Scientist

FAQs

What is Bolt Biotherapeutics Inc. share price today?

Bolt Biotherapeutics Inc. share price today is $4.07 as on at the close of the market. Bolt Biotherapeutics Inc. share today touched a day high of $4.25 and a low of $3.80.

What is the 52 week high and 52 week low for Bolt Biotherapeutics Inc. share?

Bolt Biotherapeutics Inc. share touched a 52 week high of $7.20 on and a 52 week low of $3.75 on . Bolt Biotherapeutics Inc. stock price today i.e. is closed at $4.07,which is 43.47% down from its 52 week high and 8.53% up from its 52 week low.

What is Bolt Biotherapeutics Inc.'s market capitalisation today?

Bolt Biotherapeutics Inc. market capitalisation is $0.00T as on .

How to invest in Bolt Biotherapeutics Inc. Stock (BOLT) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Bolt Biotherapeutics Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Bolt Biotherapeutics Inc. Shares that will get you 0.3686 shares as per Bolt Biotherapeutics Inc. share price of $4.07 per share as on July 7, 2026 at 1:29 am IST.

What is the minimum amount required to buy Bolt Biotherapeutics Inc. Stock (BOLT) from India?

Indian investors can start investing in Bolt Biotherapeutics Inc. (BOLT) shares with as little as ₹95.395 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹953.95 in Bolt Biotherapeutics Inc. stock (as per the Rupee-Dollar exchange rate as on ). Based on Bolt Biotherapeutics Inc. share’s latest price of $4.07 as on July 7, 2026 at 1:29 am IST, you will get 2.4570 shares of Bolt Biotherapeutics Inc.. Learn more about fractional shares .

What are the returns that Bolt Biotherapeutics Inc. has given to Indian investors in the last 5 years?

Bolt Biotherapeutics Inc. stock has given -98.58% share price returns and 27.65% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?